HCV treatment decision-making substance use experiences and hepatitis C treatment decision-making among HIV/HCV coinfected adults

Substance Use and Misuse

Volumn 44, Issue 7, 2009, Pages 915-933

  Ogawa, Lisa M Fink ^a   Bova, Carol ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Decision making processes; Hepatitis C; HIV; Medication adherence; Recovery process; Relapse triggers; Sobriety; Substance use

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECISION MAKING; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIXED INFECTION; PRIORITY JOURNAL; SUBSTANCE ABUSE;

ADULT; DECISION MAKING; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; SUBSTANCE-RELATED DISORDERS;

EID: 70849134574     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080802486897     Document Type: Article

References (77)

1. Ahern, K. J. (1999). Ten tips for reflexive bracketing. Qualitative Health Research 9(3):407-411.
2. Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine 341(8):556-562.
3. Anand, B. S., Currie, S., Dieperink, E., Bini, E. J., Shen, H., Ho, S. B., et al. (2006). Alcohol use and treatment of hepatitis C virus: Results of a national multicenter study. Gastroenterology 130(6):1607-1616.
4. Backus, L. I., Boothroyd, D., Deyton, L. R. (2005). HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations. AIDS 19(Suppl 3):S13-S19.
5. Bechara, A., Martin, E. M. (2004). Impaired decision making related to working memory deficits in individuals with substance addictions. Neuropsychology 18(1):152-162.
6. Benbassat, J., Pilpel, D., Tidhar, M. (1998). Patients' p for participation in clinical decision making: A review of published surveys. Behavioral Medicine 24(2):81-88.
7. Bensley, L. S., Van Eenwyk, J., Simmons, K. W. (2000). Self-reported childhood sexual and physical abuse and adult HIV-risk behaviors and heavy drinking. American Journal of Preventive Medicine 18(2):151-158.
8. Bhattacharya, R., Shuhart, M. C. (2003). Hepatitis C and alcohol: Interactions, outcomes and implications. Journal of Clinical Gastroenterology 36:242-252.
9. Bova, C., Jaffarian, C., Himlan, P., Mangini, L., Ogawa, L. (2008). The symptom experience of HIV/HCV coinfected adults. Journal of the Association of Nurses in AIDS Care 19(3), 170-180.
10. Bova, C., Ogawa, L. (2005). HIV-infected patients' experiences with hepatitis C evaluation and treatment. Paper presented at the 17thAnnual Scientific Sessions of the Eastern NursingResearch Society, New York, NY.
11. Bradizza, C. M., Stasiewicz, P. R., Paas, N. D. (2006). Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: A review. Clinical Psychology Review, 26:162-178.
12. Carrat, F., Bani-Sadr, F., Pol, S., Rosenthal, E., Lunel-Fabiani, F., Benzekri,A., et al. (2004). Pegylated interferon alfa-2b vs. standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIVinfected patients: A randomized controlled trial. JAMA, 292(23):2839-2848.
13. Centers for Disease Control. (1998). Recommendations for prevention and control of Hepatitis C Virus (HCV) infection and HCV-related chronic disease. Available at: Http://wonder. cdc.gov/wonder/prevguid/m0055154/m0055154.asp. Accessed on February 6, 2008.
14. Chang, A., Skole, K., Gautam, M., Schmutz, J., Black, M., Thomas, R., et al. (2005). The impact of past alcohol use on treatment response rates in patients with chronic hepatitis C. Aliment Pharmacology & Therapeutics, 22:701-706.
15. Conigliaro, J., Gordon, A. J., McGinnis, K. A., Rabeneck, L., Justice, A. C. (2003). How harmful is hazardous alcohol use and abuse in HIV infection: Do health care providers know who is at risk? Journal of Acquired Immune Deficiency Syndromes, 33(4):521-525.
16. Cooper, C. L., Cameron, D. W. (2005). Effect of alcohol use and highly active antiretroviral therapy on plasma levels of hepatitis C virus (HCV) in patients coinfected with HIV and HCV. Clinical Infectious Diseases, 41(Suppl. 1):S105-S109.
17. Creswell, J. W. (2002). Research design: Qualitative, quantitative, and mixed methods approaches (2nd ed.). Thousand Oaks, CA: Sage Publications, Inc.
18. M. C., Garfein, R. S., Monterroso, E., Brown, D., Vlahov, D. (2000). Correlates of HIV infection among young adult short-term injection drug users. AIDS, 14(6):717-726. (Pubitemid 30229351)
19. Fishbein, D. A., Lo, Y., Reinus, J. F., Gourevitch, M. N., Klein, R. S. (2004). Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. Journal of Acquired Immune Deficiency Syndromes, 37(3):1367-1375.
20. Fleming, C. A., Craven, D. E., Thornton, D., Tumilty, S., Nunes, D. (2003). Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: Low eligibility for interferon treatment. Clinical Infectious Diseases, 36(1):97-100.
21. Fleming, C. A., Tumilty, S., Murray, J. E., Nunes, D. (2005). Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: Need for team care. Clinical Infectious Diseases, 40(Suppl 5):S349-S354.
22. Fraenkel, L.,McGraw, S.,Wongcharatrawee, S., Garcia-Tsao,G. (2006). Patients' experiences related to anti-viral treatment for hepatitis C. Patient Education and Counseling, 62(1):148-155.
23. Fraenkel, L., McGraw, S., Wongcharatrawee, S., Garcia-Tsao, G. (2005). What do patients consider when making decisions about treatment for hepatitis C? American Journal of Medicine 118:1387-1391.
24. Fultz, S. L., Justice, A. C., Butt, A. A., Rabeneck, L.,Weissman, S., Rodriguez-Barradas, M. (2003). Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection. Clinical Infectious Diseases, 36(8):1039-1046.
25. Galai, N., Safaeian, M., Vlahov, D., Bolotin, A., Celentano, D. D. (2003). Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988-2000: Description and determinants. American Journal of Epidemiology, 158(7):695-704.
26. Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., Nelson, K. E. (1996). Viral infections in shortterm injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health, 86(5):655-661.
27. Hagan, H., Thiede, H., Des Jarlais, D. C. (2005). HIV/hepatitis C virus co-infection in drug users: Risk behavior and prevention. AIDS, 19(Suppl 3):S199-S207.
28. Hops, H., Tildesley, E., Lichtenstein, E., Ary, D., Sherman, L. (1990). Parent-adolescent problemsolving interactions and drug use. American Journal of Drug&Alcohol Abuse, 16(3-4):239-258.
29. Hyman, S. M., Garcia, M., Sinha, R. (2006). Gender specific associations between types of childhood maltreatment and the onset, escalation and severity of substance use in cocaine dependent adults. American Journal of Drug & Alcohol Abuse, 32(4):655-664.
30. Johnsen, L. W., Harlow, L. L. (1996). Childhood sexual abuse linked with adult substance use, victimization, and AIDS risk. AIDS Education and Prevention, 8(1):44-57.
31. Johnson, C. A., Xiao, L., Palmer, P., Sun, P., Wang, Q., Wei, Y., et al. (2008). Affective decisionmaking deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in 10th grade Chinese adolescent binge drinkers. Neuropsychologia, 46(2):714-726. (Pubitemid 351186564)
32. Kadam, J. S., Talal, A. H. (2007). Changing treatment paradigms: Hepatitis C virus in HIV-infected patients. AIDS Patient Care & STDs, 21(3):154-168.
33. Kandel, D. B., Griesler, P.C., Lee, G., Davies, M., Schaffran, C. (2001). Parental influences on adolescentmarijuana use and the baby boom generation: Findings from the 1979-1996 National Household Surveys on drug abuse. SubstanceAbuse andMental Health Services Administration, Office of Applied Studies, Analytic Series: A-13, DHHS Publication No. (SMA) 01-3531, Rockville, MD. Available at: Http://www.eric.ed.gov/ERICDocs/data/ericdocs2sql/content storage 01/ 0000019b/80/1a/3c/e0.pdfhttp://www.eric.ed.gov/ERICDocs/data/ ericdocs2sql/content storage 01/0000019b/80/1a/3c/e0.pdf. Accessed on February 8, 2008.
34. Knafl, K. A., Howard, M. J. (1984). Interpreting and reporting qualitative research. Research in Nursing and Health, 7(1):17-24.
35. Knafl, K. A.,Webster, D. C. (1988).Managing and analyzing qualitative data. A description of tasks, techniques, and materials. Western Journal of Nursing Research, 10(2):195-218.
36. Kwiatkowski, C. F., Fortuin Corsi, K., Booth, R. E. (2002). The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction, 97(10):1289-1294.
37. Leenerts,M. H. (1999). The disconnected self: Consequence of abuse in a cohort of low-income white women living with HIV. Health Care for Women International, 20(4):381-400.
38. Lieb, R., Merikangas, K. R., Hofler, M., Pfister, H., Isensee, B.,Wittchen, H. (2002). Parental alcohol use disorders and alcohol use and disorders in offspring: A community study. Psychological Medicine, 32:63-78.
39. Mauss, S. (2006). Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their management. Journal of Hepatology 44:S114-S118.
40. McCauley, J., Kern, D. E., Kolodner, K., Dill, L., Schroeder, A. F., DeChant, H. K., et al. (1997). Clinical characteristics of women with a history of childhood abuse: Unhealed wounds. JAMA, 277(17):1362-1368.
41. McCrady, B. S. (2006). Family and other close relationships. In W. R. Miller & K. M. Carroll (Ed.), Rethinking substance abuse: what the science shows, and what we should do about it (pp. 166-181). New York: The Guilford Press.
42. Miles, M. B., Huberman, M. A. (1994). Qualitative data analysis (2nd ed.). Thousand Oaks, CA: Sage Publications, Inc.
43. Morgan, D. L. (1993). Successful focus groups: Advancing the state of the art. Newbury Park, CA: Sage.
44. Morse, J. M., Singleton, J. (2001). Exploring the technical aspects of "fit" in qualitative research. Qualitative Health Research, 11(6):841-847.
45. Murrill, C. S., Weeks, H., Castrucci, B. C., Weinstock, H. S., Bell, B. P., Spruill, C., et al. (2002). Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. American Journal of Public Health, 92(3):385-387.
46. National Institutes of Health (NIH)ConsensusDevelopment Program. (2002). Management of Hepatitis C. Available at: http://consensus.nih.gov/2002/ 2002HepatitisC2002116html.htm. Accessed on February 6, 2008.
47. Noel, X., Bechara, A., Dan, B., Hanak, C., Verbanck, P. (2007). Response inhibition deficit is involved in poor decision making under risk in nonamnesic individuals with alcoholism. Neuropsychology, 21(6):778-786.
48. Nunes, D., Saitz, R., Libman, H., Cheng, D. M., Vidaver, J., Samet, J. H. (2006). Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems. Alcoholism: Clinical and Experimental Research, 30(9):1520-1526. (Pubitemid 44272741)
49. Pol, S., Lamorthe, B., Thi, N. T., Thiers, V., Carnot, F., Zylberberg, H., et al. (1998). Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. Journal of Hepatology, 28(6):945-950.
50. Patil, R., Cotler, S. J., Banaad-Omiotek, G., McNutt, R. A., Brown, M. D., Cotler, S., et al. (2001). Physicians' preference values for hepatitis C health states and antiviral therapy: A survey. Available at: Http://www.biomedcentral.com/1471-230X/1/6. Accessed on February 7, 2008.
51. QRS International. (2007). NVivo Software (Student Version N7).
52. Redelmeier, D. A., Rozin, P., Kahneman, D. (1993). Understanding patients' decisions. Cognitive and emotional perspectives. JAMA, 270(1):72-76.
53. Restrepo, A., Johnson, T. C., Widjaja, D., Yarmus, L., Meyer, K., Clain, D. J., et al. (2005). The rate of treatment of chronic hepatitis C in patients co-infected with HIV in an urban medical centre. Journal of Viral Hepatitis, 12(1):86-90.
54. Rolfe, G. (2006). Validity, trustworthiness and rigour: Qualitative and the idea of qualitative research. Journal of Advanced Nursing, 53(3):304-310.
55. Samet, J. H., Phillips, S. J., Horton, N. J., Traphagen, E. T., Kreedberg, K. A. (2004). Detecting alcohol problems in HIV-infected patients: Use of the CAGE questionnaire. AIDS Research and Human Retroviruses, 20:151-155.
56. Sandelowski, M. (2000). Whatever happened to qualitative description? Research in Nursing and Health, 23(4):334-340.
57. Scott, C. K., Foss, M. A., Dennis, M. L. (2005). Pathways in the relapse-treatment-recovery cycle over 3 years. Journal of Substance Abuse Treatment, 28(2) (Suppl 1):S63-S72.
58. Shepard, C. W., Finelli, L., Alter, M. J. (2005). Global epidemiology of hepatitis C virus infection. The Lancet Infectious Diseases, 5(9):558-567.
59. Sherman, K. E. (2003). Implications of peginterferon use in special populations infected with HCV. Seminars in Liver Disease, 23(Suppl 1):S47-S52.
60. Sherman, K. E. (2007). New paradigms in the management of hepatitis C virus co-infections. Nature Clinical Practice Gastroenterology & Hepatology, 4(Suppl 1):S10-S16.
61. Sherman, S., Latkin, C., Gielen, A. (2001). Social factors related to syringe sharing among injecting partners: A focus on gender. Substance Use & Misuse, 36(14):2113-2136.
62. Sherman, K. E., Rouster, S. D., Chung, R. T., Rajicic, N. (2002). Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS clinical trials group. Clinical Infectious Diseases, 34(6):831-837.
63. Sulkowski, M. S., Benhamou, Y. (2007). Therapeutic issues in HIV/HCV-coinfected patients. Journal of Viral Hepatitis, 14:371-386.
64. Sun, A. P. (2007). Relapse among substance-abusing women: Components and processes. Substance Use & Misuse, 42(1):1-21.
65. Sylvestre, D. L. (2005). Treating hepatitis C virus infection in active substance users. Clinical Infectious Diseases, 40(Suppl 5):S321-S324.
66. Taylor, L. (2005). Delivering care to injection drug users coinfected with HIV and hepatitis C virus. Clinical Infectious Diseases 40:S355-S361.
67. Taylor, L. E., Costello, T., Alt, E., Yates, G., Tashima, K. (2002). Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals. AIDS, 16(12):1700-1701.
68. Thomas, D. L. (2002). Hepatitis C and human immunodeficiency virus infection. Hepatology 36(5):S201-S209.
69. Thomas, D. L., Vlahov, D., Solomon, L., Cohn, S., Taylor, E., Garfein, R., et al. (1995). Correlates of hepatitis C virus infections among injection drug users. Medicine 74(4):212-220.
70. Thompson, V. V., Ragland, K. E., Hall, C. S., Morgan, M., Bangsberg, D. R. (2005). Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons. AIDS 19(Suppl 3):S208-S214.
71. Torriani, F. J., Rodrigues-Torres, M., Rockstroh, J. K., Lissen, E., Gonzalez-Garcia, J., Lazzarin, A., et al. (2004). Peginterferon Alfa2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. New England Journal of Medicine 351:428-450.
72. Voigt, E., Schulz, C., Klausen, G., Goelz, J., Mauss, S., Schmutz, G., et al. (2006). Pegylated interferon [alpha]-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients. Journal of Infection 53(1):36-42.
73. Von Unger, H., Collins, P. Y. (2005). Transforming the meaning of HIV/AIDS in recovery from substance use: A qualitative study of HIV-positive women in New York. Health Care for Women International 26(4):308-324.
74. Widom, C. S., Marmorstein, N. R.,White, H. R. (2006). Childhood victimization and illicit drug use in middle adulthood. Psychology of Addictive Behaviors 20(4):394-403.
75. Widom, C. S., Weiler, B. L., Cottler, L. B. (1999). Childhood victimization and drug abuse: A comparison of prospective and retrospective findings. Journal of Consulting & Clinical Psychology 67(6):867-880.
76. Wills, C. E., Holmes-Rovner, M. (2006). Integrating decision making and mental health interventions research: Research directions. Clinical Psychology (New York) 13(1):9-25.
77. Yucel, M., Lubman, D. I., Solowij, N., Brewer, W. J. (2007). Understanding drug addiction: A neuropsychological perspective. Australian & New Zealand Journal of Psychiatry 41(12):957-968.